Rite Aid Corp (RAD)
$9.72 0.00 (0.00%)
6:57 EDT RAD Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 10.37B
PE Ratio -28.59
Volume (Avg. Vol.) 143
Day's Range 9.72 - 9.72
52-Week Range 7.49 - 23.88
Dividend & Yield N/A (N/A)
RAD Stock Predictions, Articles, and Rite Aid Corp News
- From InvestorPlace
- From the Web
Rite Aid and friends could easily be exceptions to that trend. Price action in PBM equities this year is, arguably, pricing in not only a victory by former Vice President Joe Biden, but the Democrats controlling both houses of Congress come January 2021. That would make it easy for the party to attack the issue of high drug prices, making RAD stock and rivals vulnerable in the process.
RAD stock seemed like a winner under new management, but the fiscal Q2 report spotlights what's standing in the company's way.
Investors trying to pick election stocks should look at names that are likely to perform well no matter who occupies 1600 Pennsylvania Avenue.
Penn National gaming, UnitedHealth, Rite Aid and Norwegian Cruise Line were our top stock trades for Monday. So, let's look at the charts.
Rite Aid earnings on Thursday have RAD stock falling hard despite the company beating Wall Street's EPS and revenue estimates.
Rite Aid is dropping a facial-recognition technology because of its links with now-problematic Chinese firms.
RAD stock spiked after fiscal first quarter earnings last month. But that good news is offset by worrisome trends facing the sector as a whole.
Should the economy not bounce back following the coronavirus, you’ll want to look at these recession-resistant stocks to buy.
Rite-Aid stock isn't breaking down, but it's certainly not thriving. I don't want mediocre. I want stocks that have long-term growth plans.
Rite Aid earnings have RAD stock rising after the company beat Wall Street's expectations for revenue and per-share numbers for the quarter.
Rite Aid, Alpha Pro Tech, Amazon and Lakeland Industries were our top stock trades from Wednesday. That said, let's look at the charts now.
Rite Aid stock should benefit from the company's turnaround. It's restructuring strategy will feed through to an eventual increase in Rite Aid stock.
Rite Aid's overly conservative comments about its outlook have made the Street underestimate the company's Q1 performance. Investors should buy Rite-Aid stock ahead of the firm's Q1 results.
While it hasn't yet been reflected in the RAD stock price, Rite Aid has been among the most responsive companies during the pandemic.
Investors are rooting for a Rite Aid turnaround, but it looks increasingly unlikely. Sell RAD stock now and look for better opportunities.
Several healthcare stocks have jumped higher based off the coronavirus pandemic. But these nine companies have a longer upside pathway.
RAD stock has stabilized in recent months, but Q4 results show a lack of growth. With disruption on the way, Rite Aid may be left behind.
Morgan Stanley, Shopify, Snap and Rite Aid were our top stock trades for Friday. That said, here's a look at the charts now.
Jobless claims data continues to paint an uninspiring outlook on the U.S. economy. Here's what happened in the stock market today.
Investors in Rite Aid Corp (RAD) saw new options become available today, for the December 18th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RAD options chain for the new December 18th contracts and identified one put and one call contract of particular interest.
Investors in Rite Aid Corp (RAD) saw new options become available today, for the November 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the RAD options chain for the new November 27th contracts and identified one put and one call contract of particular interest.
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Rite Aid Corp (RAD), where a total of 21,518 contracts have traded so far, representing approximately 2.2 million underlying shares. That amounts to about 42.9% of RAD's average daily trading volume over the past month of 5.0 million shares..
From Seeking Alpha
In an afternoon announcement, Rite Aid (RAD +2.7%) says it inked a deal to acquire Bartell Drugs for $95M.Bartell Drugs is a family-owned company that generates over $550M in revenue and fills approximately 5.5M prescriptions annually across its 67 stores in Seattle and throughout King, Snohomish and Pierce counties in Washington state.
Navellier RatingsPowered by Portfolio Grader